Bench & Bedside Seminar/ Part I: Uncoupling Interferon Signaling

and Antigen Presentation to Overcome Immunotherapy Resistance/

Part II: A 5-day Neoaduvant Phase 2 Study in Sarcoma

Anusha Kalbasi, MD

Assistant Professor, Radiation Oncology – Molecular & Cellular Oncology,

David Geffen School of Medicine at UCLA 

Contact Nancy Presseau – npresseau@mednet.ucla.edu

Website: https://cancer.ucla.edu/news-events/events-calendar/grid-view/-curm-10/-cury-2018